Search results for

Host Michel Martin speaks with George Zimmerman's attorney, Craig Sonner. Nationwide protests have put Zimmerman at the focal point of a debate about race and justice. The neighborhood watch volunteer is accused of shooting unarmed Florida teen Trayvon Martin.

Journalist Peter Beinart supports Israel but thinks the Jewish settlements in the West Bank are compromising Israel's commitment to democracy. He has proposed a boycott of goods made in those Jewish settlements.

Peter Beinart's new book, The Crisis of Zionism, argues that Israel cannot be a true democratic state as long as there are settlements in the West Bank and calls for a boycott of goods made in those settlements. Gary Rosenblatt, publisher of The Jewish Week of New York, disagrees with this argument.

Shopping apps and retail websites give consumers the power to compare prices, read reviews and shop on the go. Stephanie Clifford, business reporter at The New York Times and market researcher Paco Underhill discuss how many brick-and-mortar stores are altering pricing strategies.

NPR's Neal Conan reads from listener comments on previous show topics including extreme rivalries in sports, those living with obsessive-compulsive disorder and the legacy of legendary women's basketball coach Pat Summit.

So many fantasy classics are written with young readers in mind — books like Alice in Wonderland and Harry Potter. But for the adult who loves to escape into new and magical universes, author Lyndsay Faye recommends these three reads. Have a favorite magical novel? Let us know in the comments.

The weather service says there is considerable damage in their wake.

With help from Dan Auerbach of The Black Keys, Dr. John returns to the spooky, percussive sounds of his first records on Locked Down.

In February, North Korea agreed to freeze uranium enrichment and missile tests and allow international nuclear inspectors — and then immediately announced a rocket launch. North Korea watchers are puzzled by the mixed messages and wonder who is calling the shots in a country with a new, untested leader.

In 2007, Congress created a public-private foundation to support research of interest to the FDA. Critics said this amounted to a new way for industry groups to influence the agency's decisions, and any FDA funding for the foundation was blocked for years. That's about to change.